Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma-Reference-Cited by-同舟云学术

Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma

Published:2000-06 Issue:6 Volume:84 Page:594-598
ISSN:1081-1206
Container-title:Annals of Allergy, Asthma & Immunology
language:en
Short-container-title:Annals of Allergy, Asthma & Immunology

Author:

Amayasu Hideaki,Yoshida Satoshi,Ebana Shoichi,Yamamoto Yoshiharu,Nishikawa Tetsuo,Shoji Tatsuhiro,Nakagawa Hiroshi,Hasegawa Hiroshi,Nakabayashi Masaru,Ishizaki Yuko

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology

Reference19 articles.

1. Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma;Miyatake;Chest,1991

2. Inhibition of methylpredonisolone elimination in the presence of erythromycin therapy;LaForce;J Allergy Clin Immunol,1983

3. Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5;Adachi;J Allergy Clin Immunol,1996

4. Standards for the diagnosis and care of patients with chronic obstructive pulmonary diseases (COPD) and asthma;American Thoracic Society;Am Rev Respir Dis,1987

5. Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma;Niimi;Clin Exp Allergy,1998

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis of macrolides in the management of adult patients with asthma;Allergology International;2024-07

2. Obesity and Insulin Resistance in Asthma Pathogenesis and Clinical Outcomes;Biomedicines;2024-01-12

3. Macrolides and Asthma Therapy;Progress in Inflammation Research;2024

4. Immunomodulatory Effects of Macrolides Considering Evidence from Human and Veterinary Medicine;Microorganisms;2022-12-09

5. Non-typeable Haemophilus influenzae airways infection: the next treatable trait in asthma?;European Respiratory Review;2022-09-20